These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21323181)

  • 1. Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population.
    Satirapoj B; Supasyndh O; Mayteedol N; Chaiprasert A; Choovichian P
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):176-83. PubMed ID: 21323181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of chronic kidney disease in adults with metabolic syndrome.
    Emem-Chioma PC; Siminialayi IM; Wokoma FS
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):949-54. PubMed ID: 21912024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
    Stengel B; Jaussent I; Guiserix J; Bourgeon B; Papoz L; Favier F;
    Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey.
    Ravikiran M; Bhansali A; Ravikumar P; Bhansali S; Dutta P; Thakur JS; Sachdeva N; Bhadada S; Walia R
    Diabetes Res Clin Pract; 2010 Aug; 89(2):181-8. PubMed ID: 20381187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of chronic kidney disease in elderly with metabolic syndrome and high levels of C-reactive protein: Kahrizak Elderly Study.
    Fakhrzadeh H; Ghaderpanahi M; Sharifi F; Badamchizade Z; Mirarefin M; Larijani B
    Kidney Blood Press Res; 2009; 32(6):457-63. PubMed ID: 20068351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J; Vupputuri S; Heiss G; North K; Russell M
    Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort.
    Sun F; Tao Q; Zhan S
    Nephrology (Carlton); 2010 Feb; 15(1):84-92. PubMed ID: 20377775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
    J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
    Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
    Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.